Oxyntomodulin (porcine, bovine)
CAS: 62340-29-8
Rif. 3D-MCA34029
1mg | Fuori produzione | ||
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione |
Informazioni sul prodotto
- Enteroglucagonoid
- Gut glucagon
- Glucagon, entero-
- Oxyntomodulin
- Enteroglucagon
Oxyntomodulin is a peptide hormone that is used as a pharmacological treatment for diabetes. Oxyntomodulin is an analogue of glucagon, which belongs to the family of glucagon-like peptide-1 (GLP-1) agonists. Oxyntomodulin has been shown to improve glucose tolerance and increase insulin secretion in humans and animals. This drug has also been shown to decrease appetite and improve weight loss in overweight patients with type 2 diabetes. The physiological effects of oxyntomodulin are mediated by GLP-1 receptors on multiple organs, including the pancreas, liver, gut, adipose tissue, brain, heart, and kidneys. Oxyntomodulin also inhibits the activity of dipeptidyl peptidase IV (DPP-IV), which may have therapeutic benefits for type 2 diabetes by slowing gastric emptying and increasing satiety. The administration of oxyntomodulin leads to increased mitochondrial membrane potential in